Digilib Perpustakaan Universitas Riau

  • Beranda
  • Informasi
  • Berita
  • Bantuan
  • Pustakawan
  • Pilih Bahasa :
    Bahasa Arab Bahasa Bengal Bahasa Brazil Portugis Bahasa Inggris Bahasa Spanyol Bahasa Jerman Bahasa Indonesia Bahasa Jepang Bahasa Melayu Bahasa Persia Bahasa Rusia Bahasa Thailand Bahasa Turki Bahasa Urdu

Pencarian berdasarkan :

SEMUA Pengarang Subjek ISBN/ISSN Pencarian Spesifik

Pencarian terakhir:

{{tmpObj[k].text}}
Image of analisis kesintasan pasien kanker payudara berdasarkan subtipe molekular kanker payudara
Penanda Bagikan

CD Tesis

analisis kesintasan pasien kanker payudara berdasarkan subtipe molekular kanker payudara

TANIA NUGRAH UTAMI 2110247022 - Nama Orang;

Introduction: Breast cancer is a heterogeneous disease with biological differences reflected in molecular subtypes, which influence patient survival outcomes. Survival data based on molecular subtypes in Riau Province have not previously been reported. This study aimed to analyze the association between molecular subtypes of breast cancer and patient survival at Arifin Achmad General Hospital, Pekanbaru.
Methods: This was a retrospective analytic study of breast cancer patients from 2014–2023. Data were obtained from medical records, with survival status verified through telephone follow-up or direct visits. Survival analysis was performed using the Kaplan–Meier method, and data were processed using SPSS version 26.0.
Results: A total of 1,796 patients met the inclusion criteria, with a mean age of 47.2 years. Most patients presented at a locally advanced stage (52.7%), and invasive ductal Carcinoma was the most common histopathology (69.2%). The molecular subType distribution was Luminal A 17.8%, Luminal B HER2− 16.6%, Luminal B HER2+ 25.3%, HER2 Type 26.3%, and triple-negative 14.0%. At the end of follow-up, 85.0% of patients were alive and 15.0% had died. Overall survival (OS) rates were 97.7% (1 year), 89.4% (2 years), 82.9% (3 years), 78.1% (4 years), and 79.7% (5 years). The highest 5-year OS was observed in Luminal B HER2− (84.1%), while the lowest was in triple-negative (73.6%).
Conclusion: Five-year breast cancer survival remains relatively favorable, with OS, progression-free survival, and disease-free survival indicating strong disease control and low recurrence rates. Immunohistochemistry subTypes play a cruIKal role, with Luminal B HER2− showing the best prognosis and triple-negative the worst, alongside other prognostic factors such as stage at diagnosis and presence of metastasis.
Keywords Breast cancer, Survival, Immunohistochemistry


Ketersediaan
#
Perpustakaan Universitas Riau 2110247022
2110247022
Tersedia
Informasi Detail
Judul Seri
-
No. Panggil
2110247022
Penerbit
Pekanbaru : UNRI – PASCA – Ilmu Bedah., 2025
Deskripsi Fisik
-
Bahasa
Indonesia
ISBN/ISSN
-
Klasifikasi
2110247022
Tipe Isi
-
Tipe Media
-
Tipe Pembawa
-
Edisi
-
Subjek
Ilmu Bedah
Info Detail Spesifik
-
Pernyataan Tanggungjawab
Rahmat
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
  • JUDUL
  • DAFTAR ISI
  • ABSTRAK
  • BAB I PENDAHULUAN
  • BAB II TINJAUAN PUSTAKA
  • BAB III METODE PENELITIAN
  • BAB IV HASIL DAN PEMBAHASAN
  • BAB V PENUTUP
  • BAB VI KESIMPULAN DAN SARAN
  • DAFTAR PUSTAKA
  • LAMPIRAN
Komentar

Anda harus masuk sebelum memberikan komentar

Digilib Perpustakaan Universitas Riau
  • Informasi
  • Layanan
  • Pustakawan
  • Area Anggota

Tentang Kami

As a complete Library Management System, SLiMS (Senayan Library Management System) has many features that will help libraries and librarians to do their job easily and quickly. Follow this link to show some features provided by SLiMS.

Cari

masukkan satu atau lebih kata kunci dari judul, pengarang, atau subjek

Donasi untuk SLiMS Kontribusi untuk SLiMS?

© 2026 — Senayan Developer Community

Ditenagai oleh SLiMS
Pilih subjek yang menarik bagi Anda
  • Karya Umum
  • Filsafat
  • Agama
  • Ilmu-ilmu Sosial
  • Bahasa
  • Ilmu-ilmu Murni
  • Ilmu-ilmu Terapan
  • Kesenian, Hiburan, dan Olahraga
  • Kesusastraan
  • Geografi dan Sejarah
Icons made by Freepik from www.flaticon.com
Pencarian Spesifik
Kemana ingin Anda bagikan?